Nafcillin sodium monohydrate

This classification denotes a beta-lactam antibiotic with the molecular formula C21H21N2O5S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49G3001BCK, chemically known as monosodium (2s,5r,6r)-6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate monohydrate, but more generally known as nafcillin sodium monohydrate, which bears US NIH Compound Identifier 5282391. European Medicines Agency schedules nafcillin sodium monohydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09118MIG. Most nations, for tariff purposes, schedule nafcillin sodium monohydrate under HS 29411090. SMILES: CCOC1CCC2CCCCC2C1C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[NA+].